Think Tank 2025

Community Provider Think Tank

Hinsdale Think Tank

Date: Thursday, February 13th, 2025

Time: 8:00 AM - 10:00 AM

Location: Endeavor Health Center - Hinsdale Behavioral Health, 8 Salt Creek Lane, Hinsdale

Mokena Think Tank

Date: Tuesday, February 18th, 2025

Time: 8:00 AM - 10:00 AM

Location: Endeavor Health Center - Mokena Behavioral Health, 9697 W 191st St, Mokena

Naperville Think Tank

Date: Thursday, February 20th, 2025

Time: 8:00 AM - 10:00 AM

Location: Endeavor Health Center - Naperville Behavioral Health, 1335 N Mill St, Naperville, IL

Learn your mental health risk in just five minutes

Discover your risk

Support Linden Oaks programs and services

Donate to Linden Oaks

Related Clinical Trials

Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial

This phase II trial investigates how well biomarkers on PET/CT imaging drive early discontinuation of anti-PD-1 therapy in patients with stage...

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score

This phase III trial uses the Decipher risk score to guide intensification (for higher Decipher gene risk) or de-intensification (for low Decipher...

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score

This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating...

TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

This study, known as LUNAR-2, aims to investigate the effectiveness and safety of using TTFields, delivered by the NovoTTF-200T device,...

Testing the usual treatment of radiation therapy and hormonal therapy to hormonal therapy alone for low-risk, early stage breast cancer

This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive...

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation (JANUS)

This phase II trial compares the effect of irinotecan versus oxaliplatin after long-course chemoradiation in patients with stage II-III rectal...

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05)

The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after...

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer (AZUR-2)

The primary purpose of this study is to evaluate the efficacy of perioperative dostarlimab compared with standard of care (SOC) in participants...

View All

News

View All

Edward-Elmhurst Health, NorthShore University HealthSystem, Northwest Community Healthcare and Swedish Hospital are now united under one name: Endeavor Health Our Chicagoland-based integrated health system is committed to setting a new standard for healthcare by bringing together pioneering, world-class care and a seamless, personalized experience for patients.

If you have reached this screen, your current device or browser is unable to access the full Edward-Elmhurst Health Web site.

To see the full site, please upgrade your browser to the most recent version of Safari, Chrome, Firefox or Internet Explorer. If you cannot upgrade your browser, you can remain on this site.

Think Tank 2025

Community Provider Think Tank

Hinsdale Think Tank

Mokena Think Tank

Naperville Think Tank

Learn your mental health risk in just five minutes

Support Linden Oaks programs and services

Newsletter

Sign up for our newsletter

Related Clinical Trials

News